Gerald Chan
Director, CHINOOK THERAPEUTICS, INC.
Companies
- Apellis Pharmaceuticals, Inc.Board member Nov 8, 2017 to now1
- CHINOOK THERAPEUTICS, INC.Board member Apr 14, 2015 to Jun 8, 20182
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Apellis Pharmaceuticals, Inc.0 shares3May 14, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- May 14, 2026Returned to company 3,544 shares of Apellis Pharmaceuticals, Inc.3
- May 14, 2026Returned to company 3,877 shares of Apellis Pharmaceuticals, Inc.3
- May 14, 2026Returned to company 7,961 shares of Apellis Pharmaceuticals, Inc.3
- May 14, 2026Returned to company 5,744 shares of Apellis Pharmaceuticals, Inc.3
- May 14, 2026Returned to company 3,062 shares of Apellis Pharmaceuticals, Inc.3
- May 14, 2026U 25,666 shares of Apellis Pharmaceuticals, Inc.3
- Jan 1, 2026Granted 7,961 shares of Apellis Pharmaceuticals, Inc.4
- Jan 1, 2025Granted 6,267 shares of Apellis Pharmaceuticals, Inc.5
- Jan 1, 2024Granted 3,341 shares of Apellis Pharmaceuticals, Inc.6
- Jan 1, 2023Granted 3,867 shares of Apellis Pharmaceuticals, Inc.7
- Jan 1, 2022Granted 4,230 shares of Apellis Pharmaceuticals, Inc.8
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARForm 4 filed Jan 5, 2026
- 5SEC EDGARForm 4 filed Jan 3, 2025
- 6SEC EDGARForm 4 filed Jan 2, 2024
- 7SEC EDGARForm 4 filed Jan 4, 2023
- 8SEC EDGARForm 4 filed Jan 4, 2022